Expectations trend
FY2028 · fiscal year ending 2028-01-31 · fmp
NASDAQConsumer DiscretionaryApparel - ManufacturersSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.
Next-FY EPS estimate change · 30 days
1.08 → 1.30 EPS · FY ending Jan 31, 2028 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 1 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for VNCE yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Successfully integrate OVO brand | Vince is expanding its multi-brand platform with the OVO acquisition. | Intact | OVO sales do not exceed $50 million by FY30 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “The Company sees opportunity to grow OVO sales to over $100 million and deliver Adjusted EBITDA margins in the low double digit percentage range by fiscal 2030.” “October's Very Own ("OVO") Acquisition As previously announced on August 27, 2026, the Company completed the acquisition of the operating business of OVO, a globally recognized lifestyle brand which delivered nearly $50 million in sales in calendar year 2025.” |
Compare these dated observations with the operating requirements above
FY2028 · fiscal year ending 2028-01-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Dec 8, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a small-cap, higher-risk apparel business with an emerging multi-brand growth strategy, rather than an established durable compounder. The thesis has improved recently from mixed to mildly favorable, but remains in a watch state because performance still trails its industry cohort and earnings are loss-making.
VNCE is cheap versus peers, while the valuation signal says expectations are justified and fragility is low. The expectations gap is negative, suggesting the market is not assuming a strong outcome, but confidence in that reading is medium.
Near term, recent results show revenue growth in both direct-to-consumer and wholesale, alongside higher operating income; the latest cited quarter also followed an earnings beat after a miss in June. Management has completed the OVO acquisition and aims to grow its sales, though profitability remains uneven and recent financial performance is still below the industry cohort.
Over the multi-year view, the thesis depends on sustaining growth across sales channels and turning operating improvement into durable profitability. OVO’s expansion is a key execution test, with management aiming to grow its sales to over $100 million by 2030. Near-term sector signals also matter: continued strength from apparel bellwethers could support momentum, while weaker results or slower GDP growth could weigh more heavily on this growth-sensitive business.
The 1-to-3-year setup has improved, and the low expectations reflected in a cheap peer valuation leave room for operational progress to matter. But losses, elevated risk, and execution needs make the thesis conditional. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Improve operating income margins | A supporting condition in Vince Holding Corp's published investment case. The stated target is >=15% operating margin. | Intact | operating margin falls below 10% next fiscal year | Operating margin: 16.57% FY2026-Q2; GAAP. Published target: >=15% operating margin. Annual target cannot be compared with a quarterly or TTM observation. Sep 11, 202616.570891 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “• Income from operations was $13.6 million compared to income from operations of $11.2 million in the same period last year.” “• Gross profit was $49.8 million, or 60.9% of net sales, compared to gross profit of $36.9 million, or 50.4% of net sales, in the second quarter of fiscal 2025.” Delivery assessment Nov 4, 2026 |
Achieve revenue growth in direct-to-consumer and wholesale segments | A primary condition in Vince Holding Corp's published investment case. The stated target is >=8% YoY. | Improving | falls below 8% YoY revenue growth next fiscal year | Revenue growth: 11.67% FY2026-Q2; GAAP. Published target: >=8% YoY. Annual target cannot be compared with a quarterly or TTM observation. Sep 11, 202611.669693 percent · calculatedLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 1 of 1 supplied quarters. Management reported: “For the second quarter ended August 1, 2026: • Total Company net sales increased 11.7% to $81.8 million compared to $73.2 million in the second quarter of fiscal 2025.” “The year-over-year increase was driven by a 13.7% increase in the direct-to-consumer segment and a 10.4% increase in the wholesale segment.” Delivery assessment Nov 4, 2026 |
Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.71 → $1.30 · observed estimates
$0.34B → $0.40B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-09-07 | $0.71 | $337,258,500 | 1 / 2 |
| 2026-09-08 | $0.71 | $337,258,500 | 1 / 2 |
| 2026-09-09 | $0.71 | $337,258,500 | 1 / 2 |
| 2026-09-10 | $0.71 | $337,258,500 | 1 / 2 |
| 2026-09-11 | $0.81 | $366,506,000 | 1 / 2 |
| 2026-09-12 | $1.08 | $397,915,000 | 1 / 2 |
| 2026-09-13 | $1.08 | $397,915,000 | 1 / 2 |
| 2026-09-14 | $1.08 | $397,915,000 | 1 / 2 |
| 2026-09-15 | $1.08 | $397,915,000 | 1 / 2 |
| 2026-09-16 | $1.08 | $397,915,000 | 1 / 2 |
| 2026-09-17 | $1.08 | $397,915,000 | 1 / 2 |
| 2026-09-18 | $1.08 | $397,915,000 | 1 / 2 |
| 2026-09-19 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-09-20 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-09-21 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-09-22 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-09-23 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-09-24 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-09-25 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-09-26 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-09-27 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-09-28 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-09-29 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-09-30 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-10-01 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-10-02 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-10-03 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-10-04 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-10-05 | $1.08 | $402,818,000 | 1 / 2 |
| 2026-10-06 | $1.30 | $400,276,667 | 1 / 2 |
| 2026-10-07 | $1.30 | $400,276,667 | 1 / 2 |
| 2026-10-08 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-09 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-10 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-11 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-12 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-13 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-14 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-15 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-16 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-17 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-18 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-19 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-20 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-21 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-22 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-23 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-24 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-25 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-26 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-27 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-28 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-29 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-30 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-10-31 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-11-01 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-11-02 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-11-03 | $1.30 | $400,270,667 | 1 / 2 |
| 2026-11-04 | $1.30 | $400,270,667 | 1 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.